ROLE OF WEIGHT LOSS MEDICATIONS IN THE MANAGEMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE (NASH) - DR. HENRY FRIESEN LECTURE (CSEM-005)

Thursday, October 26, 2023

16:30 – 17:30 EST

Location: Palais, 516AB

Presenter(s)

Melanie G. Cree, MD, PhD (she/her/hers)

Associate Professor
University of Colorado Anschutz/Children's Hospital Colorado
University of Colorado Anschutz/Children's Hospital Colorado

Disclosure(s):

Melanie G. Cree, MD, PhD: Amino Co: Other Research Support (includes receipt of drugs, supplies, equipment or other in-kind support) (Ongoing); Pollie, Inc: Consultant/Advisory Board (Ongoing)

Naomi Severin, MD, FRCPC: Dexcom: Consultant/Advisory Board (Ongoing)

Learning Objectives / Objectifs d'apprentissage:

At the end of this session participants will be able to / Au terme de cette conférence, vous serez:

Review the pathophysiology of NASH in relation to various insulin resistance states;
Name new guideline recommendations for the screening for NASH; and
Indicate novel treatments for the management of NASH.